Evidence map›Paper›PMID 26742847›Full record

ArticleThe Journal of biological chemistry2016

Identification of Glycosylation Sites Essential for Surface Expression of the CaVα2δ1 Subunit and Modulation of the Cardiac CaV1.2 Channel Activity.

Marie-Philippe Tétreault, Benoîte Bourdin, Julie Briot, Emilie Segura, Sylvie Lesage, Céline Fiset, Lucie Parent

Abstract read
In one paragraph

Article in The Journal of biological chemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Acute phosphatidylinositol 4,5 bisphosphate depletion destabilizes sarcolemmal expression of cardiac L-type CaProceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. The life cycle of voltage-gated CaNeuronal signaling · 2021
    Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Reduced myocyte complex N-glycosylation causes dilated cardiomyopathy.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2019
    Article
  19. A three-way inter-molecular network accounts for the CaThe Journal of biological chemistry · 2018
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Marie-Philippe TétreaultFrom the Départment de Physiologie Moléculaire et Intégrative, Faculté de Médecine, and.
Benoîte BourdinFrom the Départment de Physiologie Moléculaire et Intégrative, Faculté de Médecine, and.
Julie BriotFrom the Départment de Physiologie Moléculaire et Intégrative, Faculté de Médecine, and.
Emilie SeguraFrom the Départment de Physiologie Moléculaire et Intégrative, Faculté de Médecine, and.
Sylvie LesageDépartment de Microbiologie, Infectiologie, and Immunologie, Faculté de Médecine, Centre de Recherche de l'Hôpital Maisonneuve-Rosemont, Université de Montréal, Montréal, Québec H3C 3J7, Canada.
Céline FisetFaculté de Pharmacie, Institut de Cardiologie de Montréal and.
Lucie ParentFrom the Départment de Physiologie Moléculaire et Intégrative, Faculté de Médecine, and lucie.parent@umontreal.ca.ORCID http://orcid.org/0000-0002-7932-4264

Funding

Medical Research Council 130256
6 · The paper itself

Abstract

Alteration in the L-type current density is one aspect of the electrical remodeling observed in patients suffering from cardiac arrhythmias. Changes in channel function could result from variations in the protein biogenesis, stability, post-translational modification, and/or trafficking in any of the regulatory subunits forming cardiac L-type Ca(2+) channel complexes. CaVα2δ1 is potentially the most heavily N-glycosylated subunit in the cardiac L-type CaV1.2 channel complex. Here, we show that enzymatic removal of N-glycans produced a 50-kDa shift in the mobility of cardiac and recombinant CaVα2δ1 proteins. This change was also observed upon simultaneous mutation of the 16 Asn sites. Nonetheless, the mutation of only 6/16 sites was sufficient to significantly 1) reduce the steady-state cell surface fluorescence of CaVα2δ1 as characterized by two-color flow cytometry assays and confocal imaging; 2) decrease protein stability estimated from cycloheximide chase assays; and 3) prevent the CaVα2δ1-mediated increase in the peak current density and voltage-dependent gating of CaV1.2. Reversing the N348Q and N812Q mutations in the non-operational sextuplet Asn mutant protein partially restored CaVα2δ1 function. Single mutation N663Q and double mutations N348Q/N468Q, N348Q/N812Q, and N468Q/N812Q decreased protein stability/synthesis and nearly abolished steady-state cell surface density of CaVα2δ1 as well as the CaVα2δ1-induced up-regulation of L-type currents. These results demonstrate that Asn-663 and to a lesser extent Asn-348, Asn-468, and Asn-812 contribute to protein stability/synthesis of CaVα2δ1, and furthermore that N-glycosylation of CaVα2δ1 is essential to produce functional L-type Ca(2+) channels.

Indexed as

Protein Processing, Post-TranslationalAmino Acid SubstitutionAnimalsAnimals, NewbornCalcium Channels, L-TypeCell MembraneCells, CulturedGlycosylationHEK293 CellsHumansLuminescent ProteinsMolecular WeightMutagenesis, Site-DirectedMyocytes, CardiacPoint MutationProtein StabilityCacna2d1 protein, ratCalcium Channels, L-TypeL-type calcium channel alpha(1C)Luminescent ProteinsRecombinant Fusion ProteinsRecombinant Proteinscalcium channelconfocal microscopyelectrophysiologyflow cytometryion channelmolecular imagingN-linked glycosylationtrafficking

Identifiers

PMID26742847
PMCPMC4813503

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.